The slip
PARKINSON RECEIPTno. 8598
24 Oct 2026, 11:30 UTCdopamine neurons, braak
predictionMT2A in dopamine neurons tracks Braak Lewy-body stage
registered024ef31700da3b0d
discovery+0.42 p=0.266 n=9
replication+0.00 p=1.000 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.42, p 0.266)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT26820c83da02326e42ad20c6…
follows 2eaa8ea9547b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8598: MT2A in dopamine neurons, braak
- power
- full sample +0.19 (p 0.444, n 18), 95% CI -0.30 to +0.60. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.19 (p 0.444, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.24 (p 0.337, n 18). could be the mix.
- skeptic
- leave-one-out range +0.09 to +0.33, sign flips 0; without severely affected donors +0.19 (p 0.444, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MT2A in dopamine neurons.
case closed: nothing better to follow up.